Compare Stocks › BXP vs JNJ

BXP, Inc. (BXP) vs Johnson & Johnson (JNJ): Which Is the Better Buy in 2026?

As of 2026-11-01, BXP is overvalued at $63, with a DCF intrinsic value of $0 and a margin of safety of -100%. JNJ is overvalued at $273, with an intrinsic value of $203 and a margin of safety of -35%. Of the two, JNJ has the wider margin of safety.

BXP
BXP, Inc.
$62.80
VS
JNJ
Johnson & Johnson
$273.20

Rewards

BXP
  • ★Trailing P/E of 18.8x is 92% below the historical average of 233.8x — potentially undervalued relative to its own history.
JNJ
  • ★Johnson & Johnson has maintained ROIC above 15% for 4 consecutive years, indicating a durable competitive advantage.
  • ★Gross margin of 67.8% indicates strong pricing power — typical of businesses with significant intellectual property or brand strength.
  • ★Johnson & Johnson scores 90/100 on the Economic Moat Score (Wide Moat), with revenue predictability as the strongest competitive dimension.

Risks

BXP
  • ⚠PEG ratio of 2.33 indicates the stock is expensive relative to its expected growth — the market may be pricing in more growth than analysts project.
  • ⚠High leverage (2.03x net debt/equity) combined with thin interest coverage (-1.0x) poses financial risk.
  • ⚠Net debt/EBITDA of 8.5x indicates heavy leverage — it would take over 4 years of EBITDA to pay off net debt.
JNJ
  • ⚠FCF yield of 2.8% is below 3%, meaning the market is pricing in substantial future growth to justify the current price.
  • ⚠Trailing P/E of 41.5x is 108% above the historical average of 20.0x — the stock trades at a premium to its own history.
  • ⚠PEG ratio of 3.07 indicates the stock is expensive relative to its expected growth — the market may be pricing in more growth than analysts project.

Key Valuation Metrics

Learn more →
BXP
JNJ
Valuation
N/A
Free Cash Flow
$18.50B
N/A
FCF Yield
2.81%
18.80
Trailing P/E
41.46
30.11
Forward P/E
23.52
Quality & Moat
3.51%
ROIC
16.01%
8.96%
ROE
20.02%
59.24%
Gross Margin
67.77%
2.33
PEG Ratio
3.07
Balance Sheet Safety
2.03
Net Debt / Equity
0.34
N/A
Interest Coverage
N/A
8.55
Net Debt / EBITDA
0.79
4.46%
Dividend Yield
1.96%
BXP: 3Ties: 1JNJ: 6
BXPJNJ

Historical Fundamentals

Learn more →
BXP

Price ÷ Earnings Per Share — how many years of current earnings you're paying for at today's price. Lower P/E may indicate undervaluation. The dashed forward point is the forward P/E — today's price ÷ analyst consensus EPS.

JNJ

Price ÷ Earnings Per Share — how many years of current earnings you're paying for at today's price. Lower P/E may indicate undervaluation. The dashed forward point is the forward P/E — today's price ÷ analyst consensus EPS.

Price ÷ Earnings Per Share — how many years of current earnings you're paying for at today's price. Lower P/E may indicate undervaluation. The dashed forward point is the forward P/E — today's price ÷ analyst consensus EPS.

$1 Retained Earnings Test

Learn more →
BXP
N/A
Net losses over 3 years — test not applicable
Company had negative cumulative retained earnings
Σ Retained
$-1.54B
Δ Market Cap
+$105.1M
Buffett's "$1 Test": For every $1 of earnings retained, has management created at least $1 of market value?
> $1 created per $1 retained = Value Creator · < $1 created = Value Destroyer
JNJ
$0.91
created per $1 retained over 3 years
Mediocre Allocator
Σ Retained
$40.05B
Δ Market Cap
+$36.63B
Buffett's "$1 Test": For every $1 of earnings retained, has management created at least $1 of market value?
> $1 created per $1 retained = Value Creator · < $1 created = Value Destroyer

Buffett's "$1 Test": For every $1 of earnings retained, has management created at least $1 of market value?
> $1 created per $1 retained = Value Creator · < $1 created = Value Destroyer

Discounted Cash Flow (DCF) Analysis

Learn more →
BXP
Insufficient Data
Enter initial FCF to calculate intrinsic value
Current Price: $62.80
Fair Value: $0.00
Strongly undervalued
Undervalued
Fairly valued
Overvalued
Strongly overvalued
JNJ
34.7% Overvalued
Price is 34.7% above estimated fair value
Current Price: $273.20
Fair Value: $202.84
Strongly undervalued
Undervalued
Fairly valued
Overvalued
Strongly overvalued

Reverse DCF — Market-Implied Growth

Learn more →
BXP

Requires positive FCF to compute implied growth rate.

JNJ

What growth rate is the market pricing in at $273?

+9.9%
Market-Implied Owner Earnings Growth
Standard FCF implies +16.1%

The market implies +9.9% Owner Earnings growth, above historical trends.

Standard FCF implies a demanding +16.1%, reflecting heavy growth investment.

Economic Moat Score

Learn more →
BXP
56/100
Narrow Moat
70+ Wide · 40-69 Narrow · <40 None

Narrow moat with revenue predictability as the key competitive advantage. Improving reinvestment efficiency would strengthen the moat.

Composite score measuring competitive advantage durability across four dimensions: returns above cost of capital, pricing power stability, revenue predictability, and capital efficiency. Based on 5 years of fundamental data.
JNJ
90/100
Wide Moat
70+ Wide · 40-69 Narrow · <40 None

Wide moat with strength across all dimensions. Revenue Predictability is the standout factor.

Composite score measuring competitive advantage durability across four dimensions: returns above cost of capital, pricing power stability, revenue predictability, and capital efficiency. Based on 5 years of fundamental data.

Forensic Accounting

Learn more →
BXP
-2.79
Unlikely Manipulator
Above -1.78 = likely manipulator · -2.22 to -1.78 = grey zone

M-Score Trend

Beneish's 8-variable model estimates the probability of earnings manipulation. An M-Score above -1.78 signals elevated risk — companies in this range have historically been 3-5× more likely to be manipulating earnings. Scores between -2.22 and -1.78 fall in a grey zone warranting further investigation.
JNJ
-2.31
Unlikely Manipulator
Above -1.78 = likely manipulator · -2.22 to -1.78 = grey zone

M-Score Trend

Beneish's 8-variable model estimates the probability of earnings manipulation. An M-Score above -1.78 signals elevated risk — companies in this range have historically been 3-5× more likely to be manipulating earnings. Scores between -2.22 and -1.78 fall in a grey zone warranting further investigation.

Beneish's 8-variable model estimates the probability of earnings manipulation. An M-Score above -1.78 signals elevated risk — companies in this range have historically been 3-5× more likely to be manipulating earnings. Scores between -2.22 and -1.78 fall in a grey zone warranting further investigation.

Ownership Breakdown

Learn more →
BXP
Insiders 0.4%Institutions 113.4%
No. of Institutional Holders818
High insider ownership aligns management incentives with shareholders — a key signal in Buffett-style analysis. Institutional concentration can indicate smart-money conviction but also crowding risk.
JNJ
Insiders 0.1%Institutions 76.8%Retail & Other 23.2%
No. of Institutional Holders5,842
High insider ownership aligns management incentives with shareholders — a key signal in Buffett-style analysis. Institutional concentration can indicate smart-money conviction but also crowding risk.

High insider ownership aligns management incentives with shareholders. Institutional concentration can indicate smart-money conviction but also crowding risk.

Insider Buying Activity

Learn more →
BXP
0
Buys (3M)
0
Buys (12M)
No open market insider purchases found.
Open market purchases · includes direct & indirect ownership · excludes option exercises
JNJ
0
Buys (3M)
1
Buys (12M)
Total value (12M): $257,688
MORIKIS JOHN G
Director
$257,688
@ $206.15 · 2025-11-26
WEINBERGER MARK A
Director
$147,220
@ $147.22 · 2024-12-12
Open market purchases · includes direct & indirect ownership · excludes option exercises

Open market purchases · includes direct & indirect ownership · excludes option exercises.

Insider Selling Activity

Learn more →
BXP
0
Sells (3M)
9
Sells (12M)
Total value (12M): $7.66M
LABELLE MICHAEL E.
Chief Financial Officer
$1.73M
@ $66.35 · 2026-06-09
KEVORKIAN ERIC G
Officer
$131,747
@ $59.88 · 2026-05-22
OTTENI PETER V
Officer
$287,186
@ $59.06 · 2026-05-20
SPANN HILARY J.
Officer
$327,997
@ $59.69 · 2026-02-27
SPANN HILARY J.
Officer
$75,592
@ $63.31 · 2026-02-05
RITCHEY RAYMOND A
Officer
$2.62M
@ $72.18 · 2025-12-01
OTTENI PETER V
Officer
$300,470
@ $72.65 · 2025-11-25
STROMAN JOHN J
Officer
$1.22M
@ $72.17 · 2025-11-12
LABELLE MICHAEL E.
Chief Financial Officer
$970,952
@ $72.34 · 2025-11-07
GARESCHE DONNA D
Officer
$145,453
@ $67.87 · 2025-03-05
SPANN HILARY J.
Officer
$891,536
@ $72.02 · 2025-02-04
Direct ownership only · excludes indirect, option exercises, planned (10b5-1) sales & derivatives
JNJ
5
Sells (3M)
14
Sells (12M)
Total value (12M): $128.54M
SCHMID TIMOTHY
Officer
$9.23M
@ $274.74 · 2026-09-02
TAUBERT JENNIFER L
Officer
$3.95M
@ $263.36 · 2026-08-17
DUATO JOAQUIN BOIX
Chief Executive Officer
$32.20M
@ $261.17 · 2026-08-13
FORMINARD ELIZABETH
Officer
$4.09M
@ $257.00 · 2026-08-06
DUATO JOAQUIN BOIX
Chief Executive Officer
$12.52M
@ $258.15 · 2026-08-05
BROADHURST VANESSA
Officer
$5.79M
@ $251.27 · 2026-07-20
WENGEL KATHRYN E
Chief Technology Officer
$2.41M
@ $241.15 · 2026-06-11
DECKER ROBERT J
Officer
$1.01M
@ $247.87 · 2026-02-27
SCHMID TIMOTHY
Officer
$324,763
@ $245.66 · 2026-02-20
SCHMID TIMOTHY
Officer
$5.53M
@ $244.33 · 2026-02-18
BROADHURST VANESSA
Officer
$1.51M
@ $243.39 · 2026-02-17
SWANSON JAMES D
Chief Technology Officer
$15.11M
@ $243.39 · 2026-02-17
WOLK JOSEPH J
Chief Financial Officer
$21.77M
@ $242.80 · 2026-02-17
REED JOHN C
Officer
$13.11M
@ $243.00 · 2026-02-17
REED JOHN C
Officer
$4.19M
@ $192.71 · 2025-10-17
TAUBERT JENNIFER L
Officer
$10.04M
@ $177.81 · 2025-09-04
DUATO JOAQUIN BOIX
Chief Executive Officer
$22.55M
@ $179.21 · 2025-08-22
WOLK JOSEPH J
Chief Financial Officer
$2.98M
@ $176.91 · 2025-08-15
REED JOHN C
Officer
$3.13M
@ $163.55 · 2025-07-17
DECKER ROBERT J
Officer
$1.16M
@ $165.88 · 2025-02-25
SCHMID TIMOTHY
Officer
$62,928
@ $156.15 · 2025-02-18
WOLK JOSEPH J
Chief Financial Officer
$2.00M
@ $153.89 · 2025-02-07
Direct ownership only · excludes indirect, option exercises, planned (10b5-1) sales & derivatives

Direct ownership only · excludes indirect, option exercises, planned (10b5-1) sales & derivatives.

🎭 Mr. Market's Mood

Learn more →
BXP
FearGreed
😐Neutral(49/100)

"Market is pricing this stock without strong emotion in either direction"

Composite sentiment score based on 6 market signals. Inspired by Buffett's "Mr. Market" allegory — fear = potential opportunity, greed = potential risk. Must be used alongside fundamental analysis, not in isolation.
JNJ
FearGreed
😏Greed(67/100)

"Market is optimistic — be cautious and ensure you have a margin of safety"

Composite sentiment score based on 6 market signals. Inspired by Buffett's "Mr. Market" allegory — fear = potential opportunity, greed = potential risk. Must be used alongside fundamental analysis, not in isolation.

Composite sentiment score based on market signals. Inspired by Buffett’s "Mr. Market" allegory — fear = potential opportunity, greed = potential risk. Must be used alongside fundamental analysis, not in isolation.

⚖️ Buffett Signal

Learn more →
BXP
⚪Awaiting DCF Data

The Buffett Signal cross-references market sentiment with DCF valuation. Configure the DCF Analysis above to generate a signal.

DCF Margin of Safety: N/AMr. Market's Mood: Neutral (49)
JNJ
⚪Awaiting DCF Data

The Buffett Signal cross-references market sentiment with DCF valuation. Configure the DCF Analysis above to generate a signal.

DCF Margin of Safety: N/AMr. Market's Mood: Greed (67)
View BXP Full AnalysisView JNJ Full Analysis

Frequently Asked Questions: BXP vs JNJ

Is BXP, Inc. or Johnson & Johnson more undervalued in 2026?▼

Based on our discounted cash flow model, JNJ trades at a -34.7% margin of safety (intrinsic value $203 vs. price $273), compared to BXP's -100.0% margin of safety (intrinsic $0 vs. $63).

Which stock has a wider economic moat, BXP, Inc. or Johnson & Johnson?▼

JNJ scores 90/100 (Wide moat), while BXP scores 56/100 (Narrow moat). The moat score measures competitive advantage durability across ROIC consistency, margin stability, revenue predictability, and reinvestment efficiency.

Is BXP, Inc. in financial distress?▼

BXP's Altman Z-Score of 0.6 places it in the Distress zone, signaling elevated bankruptcy risk. JNJ scores 3.5 (Safe zone). The Altman Z-Score is a five-factor model that predicts insolvency within two years; scores below 1.81 indicate significant distress.

Which stock has higher return on invested capital, BXP, Inc. or Johnson & Johnson?▼

JNJ earns 16.0% ROIC versus BXP's 3.5%. A higher ROIC means the company generates more profit per dollar of capital employed, a hallmark of durable competitive advantage in Buffett-style analysis.

Which dividend is safer, BXP, Inc.'s or Johnson & Johnson's?▼

JNJ's dividend earns a safety score of 79/100 (Safe), compared to BXP's 45/100 (Borderline). JNJ has raised its dividend for 3 consecutive years.